Clinical Trials

Transplantation

1. Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial - EXTended Criteria Donors
   PI Dr. Richard Formica
2. Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial
   PI Dr. Richard Formica
3. A Randomized, Open-Label Study to Compare the Safety and Efficacy of Two Different Sirolimus Regimens With a Tacrolimus + Mycophenolte Mofetil regimen in De Novo renal Allograft Recipients
   Pi Dr. Sanjay Kulkarni
4. Noninvasive Monitoring to Predict Outcome in De Novo Kidney Transplant Recipients
   Pi Richard Formica
5. A Randomized, Open-Label, Comparative Evaluation of Conversion from Calcineurin Inhibitors to Sirolimus Versus Continued Use of Calcineurin Inhibitors in Renal Allograft Recipients.
   PI Dr. Sanjay Kulkarni
6. A facilitated access program to provide Everolimus (RAD) for maintenance patients completing therapy in RAD trials in solid organ transplantation (RAD 2401)
   Pi Dr. Richard Formica

Oncology

1. Open Label, Two-Stage, Phase II Study to Evaluate the Efficacy and Tolerability of ZD6474 in Patients with Locally Advanced or Metastatic Hereditary Medullary Thyroid Carcinoma.
2. An International, Phase II, Randomized, Double-Blinded, Placebo-Controlled, Multi-Center Study to Assess the Efficacy of ZD6474 (Zactima) verses Placebo in Subjects with Unresectable Locally Advanced or Metastatic Medullary Thyroid Cancer.

View more Yale trials…